Table 3. Univariate analysis for the presence of any stent-related complication among patients who underwent follow-up bronchoscopy.
Characteristic | Odds ratio | 95% CI | P value |
---|---|---|---|
Age (>55 vs. ≤55 years) | 1.18 | 0.49–2.84 | 0.71 |
Sex (female vs. male) | 1.36 | 0.58–3.21 | 0.48 |
Indication for stent placement (malignant vs. benign) | 0.93 | 0.40–2.19 | 0.88 |
Stent location | |||
Trachea | 1.00 | Reference | – |
Carina (Y-stent) | 0.72 | 0.24–2.16 | 0.56 |
Left mainstem bronchus | 0.95 | 0.23–3.85 | 0.94 |
Right mainstem bronchus | 3.25 | 0.35–30.0 | 0.30 |
Bronchus intermedius | 2.71 | 0.76–9.63 | 0.12 |
Stent type | |||
Hybrid | 1.00 | Reference | – |
Metallic | 0.09 | 0.01–0.59 | 0.01 |
Straight silicone stent | 0.40 | 0.12–1.40 | 0.15 |
Y stent | 0.24 | 0.07–0.80 | 0.02 |
T-tube | 0.18 | 0.04–0.80 | 0.03 |
Symptoms* | |||
Any symptom (yes vs. no) | 1.88 | 0.79–4.45 | 0.15 |
Dyspnea (yes vs. no) | 2.80 | 1.06–7.35 | 0.04 |
Cough (yes vs. no) | 1.77 | 0.46–6.86 | 0.41 |
Respiratory failure (yes vs. no) | 0.40 | 0.12–1.35 | 0.14 |
*, excess secretions and dysphagia were not analyzed individually as symptoms because their incidence was too small.